UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study

BMC cancer, 2024-07, Vol.24 (1), p.1-10, Article 915

2024

Volltextzugriff (PDF)

Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial

BMC medicine, 2023-06, Vol.21 (1), p.226-226, Article 226

2023

Volltextzugriff (PDF)

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

Breast (Edinburgh), 2023-12, Vol.72, p.103597-103597, Article 103597

2023

Volltextzugriff (PDF)

In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer

Pathology oncology research, 2020-10, Vol.26 (4), p.2435-2442

2020

Volltextzugriff (PDF)

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance

EBioMedicine, 2018-06, Vol.32, p.111-118

2018

Volltextzugriff (PDF)

Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database

BMJ open, 2022-02, Vol.12 (2), p.e054135-e054135

2022

Volltextzugriff (PDF)

FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920915305-1758835920915305

2020

Volltextzugriff (PDF)

Eribulin mesylate versus eribulin plus anlotinib in patients with advanced or metastatic breast cancer: Results of a phase II study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1094-1094

2022

Volltextzugriff (PDF)

Abstract P2-13-32: Pyrotinib in combination with letrozole for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: A multicenter, single-arm, phase II trial

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-13-32

2022

Volltextzugriff (PDF)

Abstract PS13-17: Capecitabine maintaining treatment improves progression-free survival in metastatic breast cancer: A prospective observational study of 669 cases

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS13-17-PS13-17

2021

Volltextzugriff (PDF)

Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor

Clinical breast cancer, 2018-10, Vol.18 (5), p.e1149-e1163

2018

Volltextzugriff (PDF)

A novel planar tunable bandstop filter based on simple coupled-line structure

2012 3rd IEEE International Conference on Network Infrastructure and Digital Content, 2012, p.94-96

Huawu Xiao

2012

Volltextzugriff (PDF)

Circulating tumor DNA to reveal mutation profiling in relation to treatment response in different subtypes of metastatic breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12551-e12551

2018

Volltextzugriff (PDF)

Widely linear MOE receivers for uplink MC-CDMA systems with varible step size

2011 IEEE International Conference on Signal Processing, Communications and Computing (ICSPCC), 2011, p.1-3

Huawu Xiao

2011

Volltextzugriff (PDF)

Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial

EClinicalMedicine, 2024-10, Vol.76, p.102837, Article 102837

2024

Volltextzugriff (PDF)

aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

Therapeutic advances in medical oncology, 2020-05, Vol.12

2020

Volltextzugriff (PDF)

Variable step size WL-LMS algorithm for WL-MOE receiver

2010 2nd IEEE InternationalConference on Network Infrastructure and Digital Content, 2010, p.120-122

2010

Volltextzugriff (PDF)

MOE reciever with channel estimation in CDMA system

ICMMT 4th International Conference on, Proceedings Microwave and Millimeter Wave Technology, 2004, 2004, p.235-238

2004

Volltextzugriff (PDF)

Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation

World journal of gastroenterology : WJG, 2005-03, Vol.11 (11), p.1605

2005

Volltextzugriff (PDF)

Contrasting water use pattern of introduced and native plants in an alpine desert ecosystem, Northeast Qinghai–Tibet Plateau, China

The Science of the total environment, 2016-01, Vol.542 (Pt A), p.182-191

2016

Volltextzugriff (PDF)

Stable isotopes of surface water and groundwater in a typical subtropical basin in south‐central China: Insights into the young water fraction and its seasonal origin

Hydrological processes, 2022-04, Vol.36 (4), p.n/a

2022

Volltextzugriff (PDF)

Subsurface mixing of different soil water pools in a permafrost-underlain headwater catchment, Qilian Mountains, Northeastern Tibetan Plateau

Journal of hydrology (Amsterdam), 2024-01, Vol.628, p.130478, Article 130478

2024

Volltextzugriff (PDF)

Stable isotopes of atmospheric water vapour and precipitation in the northeast Qinghai‐Tibetan Plateau

Hydrological processes, 2019-11, Vol.33 (23), p.2997-3009

2019

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(44)
Tagungsberichte
(7)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study

Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance

Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database

FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial

Eribulin mesylate versus eribulin plus anlotinib in patients with advanced or metastatic breast cancer: Results of a phase II study

Abstract P2-13-32: Pyrotinib in combination with letrozole for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: A multicenter, single-arm, phase II trial

Abstract PS13-17: Capecitabine maintaining treatment improves progression-free survival in metastatic breast cancer: A prospective observational study of 669 cases

Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor

A novel planar tunable bandstop filter based on simple coupled-line structure

Circulating tumor DNA to reveal mutation profiling in relation to treatment response in different subtypes of metastatic breast cancer

Widely linear MOE receivers for uplink MC-CDMA systems with varible step size

Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trialResearch in context

Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial

aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

Variable step size WL-LMS algorithm for WL-MOE receiver

MOE reciever with channel estimation in CDMA system

Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation

Contrasting water use pattern of introduced and native plants in an alpine desert ecosystem, Northeast Qinghai–Tibet Plateau, China

Stable isotopes of surface water and groundwater in a typical subtropical basin in south‐central China: Insights into the young water fraction and its seasonal origin

Subsurface mixing of different soil water pools in a permafrost-underlain headwater catchment, Qilian Mountains, Northeastern Tibetan Plateau

Stable isotopes of atmospheric water vapour and precipitation in the northeast Qinghai‐Tibetan Plateau

Suchergebnisse filtern